BioSpace News Archive

The American Gastroenterological Association announced it will be developing educational materials and safety protocols for gastroenterologists as they work to re-open their clinical practices during the COVID-19 pandemic.

Findings, published in Urology, suggest that GPS™ results can help guide the intensity of clinical management in this higher-risk patient population

InMode Ltd., a leading global provider of innovative medical technologies, is proud to announce Health Canada certification of Evolve Tone.

Keystone Heart, LTD., a medical device innovator driven to redefine the standard of structural heart care, announced it has acquired 510 Kardiac Devices, Inc., a privately-held medical device company and makers of the Lim Transseptal System.

Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) (“Titan” or the “Company”) today announced that it has initiated a fully-virtual Probuphine ® (buprenorphine) implant Risk Evaluation and Mitigation Strategy (“REMS”) training and certification program for qualified health care providers (“HCPs”) who treat patients with Opioid U

Boston Children’s Hospital is the number one pediatric hospital in the nation for the seventh year in a row according to U.S. News & World Report’s 2020-21 Best Children’s Hospitals Honor Roll.

Cassava Sciences, Inc. (Nasdaq:SAVA), a clinical-stage biotechnology company focused on Alzheimer’s disease, today announced that the Company will be added to the Russell 2000 ® and Russell 3000 ® Indexes, effective after the close of the U.S. markets on Friday, June 26, 2020. These indexes provide institutional investors and other market participants with exposure to the performance of certain segments of the U.S. stock market. “We are plea

This high-volume laboratory test will allow for collection of blood samples using a simplified proprietary blood collection device once cleared by the FDA. This test adds to the previously announced Biomerica 10-minute finger prick antibody tests already being sold outside of the US Biomerica has filed a provisional patent on technology to allow simplified blood collection

Expansion enables full commercial scale plasmid DNA manufacturing capabilities Manufacturing program supports upcoming clinical trials, including Oncoprex in combination with Tagrisso®, which received FDA Fast Track Designation AUSTIN, Texas--( BUSINESS WIRE )-- Genprex, Inc. (“Genprex” or the “Company”) (Nasdaq: GNPX ), a clinical-stage gene therapy company developing potentially life-changing technologies for patients with cancer and dia

LifeBiotic is the leader in developing evidence based premium natural products for integrative care.